The Centers for Medicare and Medicaid Services is proposing a major change in reimbursement payments for drugs covered under Medicare Part B.

Currently, CMS says it generally pays physicians and hospital outpatient departments the average sales price of a drug, plus 6 percent.

Under the proposed change, the payment would be 2.5 percent of the average sales price plus a flat $16.80 payment.

Drugs covered may include antibiotics, as well as eye care or cancer medications. It does not cover most prescription drugs taken at home.

Advertise with us

The proposed rule will look at six different payment models that would lessen any incentive for doctors to prescribe more expensive, but not more effective, drugs to increase the reimbursement, said family physician Patrick Conway, chief medical officer for CMS.

It could also reduce or eliminate the cost to patients, who typically would have to cover 20 percent of the Part B drug’s cost.

CMS says it spent about $457 billion on prescription drugs in 2015, representing 16.7 percent of all health spending, with $20 billion spent on Part B drugs administered by physicians or staff in hospital outpatient departments.

In a media briefing call Tuesday afternoon, Dr. Conway said they’ve heard from oncologists who felt pressured by administrators to order a more expensive drug “even if not appropriate.”

The new rule, published Thursday in the Federal Register, would not prevent a physician from prescribing drugs they believe are necessary but could result in better outcomes for patients “and in smarter spending.”

Advertise with us

The proposed rule can be viewed at https://www.federalregister.gov/public-inspection.

CMS is accepting comments on the proposed rule through May 9, 2016. Testing of the new proposal will begin late this year in various regions of the U.S.

Steve Twedt: stwedt@post-gazette.com or 412-263-1963.